{"id":12710,"date":"2020-05-08T13:00:30","date_gmt":"2020-05-08T11:00:30","guid":{"rendered":"https:\/\/idibell.cat\/?p=12710"},"modified":"2020-05-16T19:49:54","modified_gmt":"2020-05-16T17:49:54","slug":"un-estudi-amb-participacio-de-lidibell-determina-el-numero-de-cicles-de-quimioterapia-optim-per-tractar-el-glioblastoma","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2020\/05\/un-estudi-amb-participacio-de-lidibell-determina-el-numero-de-cicles-de-quimioterapia-optim-per-tractar-el-glioblastoma\/","title":{"rendered":"Un estudi amb participaci\u00f3 de l’IDIBELL determina el n\u00famero de c\u00edcles de quimioter\u00e0pia \u00f2ptim per tractar el glioblastoma"},"content":{"rendered":"

Actualment, els pacients amb glioblastoma reben sis cicles de radiaci\u00f3 i de temozolomida, un tipus de quimioter\u00e0pia oral. No obstant, el n\u00famero de rondes necess\u00e0ries ha sigut objecte de debat durant durant anys. Per aquest motiu, un equip format per investigadors de l’Institut Catal\u00e0 d’Oncologia (ICO), l’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i l’Institut de Recerca en Ci\u00e8ncies de la Salut Germans Trias i Pujol (IGTP) ha dut a terme un assaig cl\u00ednic amb m\u00e9s de 150 pacients per tal de poder determinar quin \u00e9s el n\u00famero de cicles \u00f2ptim.<\/p>\n

Els resultats, publicats recentment a la revista Neuro Oncology<\/a> i finan\u00e7ats a trav\u00e9s d’una beca de l’Institut Carlos III, demostren que augmentar el n\u00famero de cicles d’aquest tipus de quimioter\u00e0pia no aporta beneficis addicionals. A m\u00e9s, l’estudi apunta que un major n\u00famero de cicles podria ser contraproduent, ja que incrementa la toxicitat del tractament.<\/p>\n

 <\/p>\n

Una \u00e0mplia participaci\u00f3<\/h4>\n

 <\/p>\n

L’estudi, que ha durat m\u00e9s de 5 anys, \u00e9s un assaig cl\u00ednic de fase II, multic\u00e8ntric i obert. \u00c9s a dir, en aquest cas, tant els pacients com els professionals eren conscients de si rebien el tractament experimental, en aquest cas 12 cicles de temozolomida, o si, per contra, van rebre nom\u00e9s els 6 cilces que actualment estan establerts a les guies cl\u00edniques.<\/p>\n

Les conclusions, tot i no ser positives, permeten tancar la discussi\u00f3 i per tant assegurar que els pacients de glioblastoma reben el millor tractament.<\/p>\n","protected":false},"excerpt":{"rendered":"

L’assaig cl\u00ednic, publicat a la revista \u2018Neuro Oncology\u2019, demostra que allargar el n\u00famero de cicles de temozolomida en pacients amb aquest tipus de tumor no aporta beneficis addicionals i incrementa la toxicitat del tractament.<\/p>\n","protected":false},"author":8,"featured_media":12711,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[332],"tags":[],"class_list":["post-12710","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer"],"publishpress_future_action":{"enabled":false,"date":"2024-09-15 00:41:00","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/12710"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=12710"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/12710\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/12711"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=12710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=12710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=12710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}